SUBSCRIBERS
Corporate digest
Published Fri, Nov 23, 2018 · 09:50 PM
Acromec
ACROMEC, a specialist engineering firm, said that the group is expected to report losses for fiscal 2018. This period refers to the 12 months ended Sept 30, 2018. The loss is due to additional cost in the construction of a pharmaceutical plant in Tuas, it said.
Shares of Acromec last traded at S$0.135.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Boeing gets a welcome respite with US$10 billion bond offering
Hong Kong vies with US in Bitcoin ETF market after crypto’s revival
Chevron CEO expects ExxonMobil arbitration resolved in coming months
Paramount replaces CEO with trio as it talks merger with Skydance
MicroStrategy posts loss on impairment charge, revenue declines
JPMorgan looks to fend off Goldman and other private credit for US$1 billion